KF
COLL icon

Krilogy Financial’s Collegium Pharmaceutical COLL Stock Holding History

Krilogy Financial’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$3K – 246
2018
Q1 		$3K Hold
100
– – ﹤0.01% 646
2017
Q4 		$2K Hold
100
– – ﹤0.01% 681
2017
Q3 		$1K Hold
100
– – ﹤0.01% 768
2017
Q2 		$1K Hold
100
– – ﹤0.01% 691
2017
Q1 		$2K Hold
100
– – ﹤0.01% 642
2016
Q4 		$2K Buy
+100
New +$1.66K ﹤0.01% 642

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Krilogy Financial's COLL Position: Q2 2018 in Review

Krilogy Financial sold out of Collegium Pharmaceutical (COLL) in Q2 2018, closing a stake of 100 shares — an estimated $3K sold.

Krilogy Financial first reported a position in COLL in Q4 2016 and held it in 6 quarters. The position peaked at $3K in Q1 2018. 133 funds tracked by Wall St. Rank hold COLL as of Q2 2018.

  • Krilogy Financial reported no remaining Collegium Pharmaceutical position as of Q2 2018 after selling out during the quarter.
  • Krilogy Financial sold 100 Collegium Pharmaceutical shares in Q2 2018, an estimated $3K.
  • Krilogy Financial first reported a position in Collegium Pharmaceutical in Q4 2016 and held it in 6 quarters.
  • Krilogy Financial's Collegium Pharmaceutical position peaked at $3K in Q1 2018.
  • 133 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2018.

Based on Krilogy Financial's 13F filing for Q2 2018, filed 15 Aug 2018.